一种聚丙烯酸接枝型荧光纳米粒子的制备、性能及细胞成像

将N-氨基-4-N-甲基哌嗪-1,8-萘酰亚胺(AMN)通过酰胺化反应接枝到聚丙烯酸链上,利用生成的聚合物在水溶液中的自组装, 制备了一种水溶性荧光纳米粒子(PAAMN).采用紫外可见光谱、核磁共振氢谱、透射电镜、动态光散射和荧光光谱方法对PAAMN进行了表征,MTT法检测其细胞相容性,最后用荧光显微镜观察其自身荧光及细胞成像效果.实验结果表明, PAAMN为球状结构,萘酰亚胺荧光团的摩尔取代度为4.1%;在生理pH条件下,以390 nm为激发波长,PAAMN在534 nm处发射较强的荧光,且光稳定性较好;在pH 4.0~10.0范围内,其荧光波长无明显变化,荧光强度随pH值增大而逐渐减小,但pH敏感程度小于AMN.PAAMN具有良好的细胞相容性,能进入细胞,且在~390 nm激发光下发射绿色荧光,可用于细胞成像.     

紫杉醇二聚体纳米前药研究进展

差的水溶性以及严重的毒副作用限制了紫杉醇(PTX)在肿瘤治疗上的应用,纳米药物递送系统的出现有望解决这一难题.通过桥连基团,将PTX修饰成二聚体前药,从而在水环境中自组装为纳米聚集体,不仅可以改善PTX在水中的溶解度,提高与高分子载体的相容性,实现超高的药物含量,还可以通过调控桥连基团,实现肿瘤微环境响应性的药物释放....     

溶剂手性转移法制备超支化共轭聚合物手性荧光纳米粒子

通过Suzuki缩合反应制备了一系列新型不同超支化结构的9,9-二辛基芴-联二噻吩交替共聚物(HF8T2s).以手性溶剂(R)-(+)-/(S)-(-)-柠檬烯为手性源,在三氯甲烷/((R)-(+)-或(S)-(-)-)柠檬烯/甲醇混合溶剂体系里,通过溶剂手性转移技术,制备了分别以三苯胺、三苯基苯和螺二芴为支化单元的超支化聚(9,9-二辛基芴-联二噻吩)手性荧光纳米粒子.在混合溶剂中形成的荧光纳米粒子的手性来源于手性溶剂(R)-(+)-/(S)-(-)-柠檬烯.以三苯胺为支化单元时,支化单元的含量为4.56%时聚合物的手性信号最强,支化单元的含量为6.76%时聚合物的手性信号消失.以三苯基苯和螺二芴为支化单元时,支化单元的含量分别为1.85%(三苯基苯)和1.78%(螺二芴)时聚合物的手性信号最强,支化单元的含量较高(三苯基苯:4.68%和6.56%,螺二芴:4.54%和6.54%)时聚合物的手性信号消失.以超支化聚合物HF8T2-TRA2(三苯胺为支化单元,支化单元含量为1.90%)为例,考察了超支化聚合物重复单元浓度、弱溶剂的种类、弱溶剂与手性溶剂比例和(R)-(+)-柠檬烯与(S)-(-)-柠檬烯比例对超支化聚合物圆二色谱光谱强度的影响.当超支化聚合物重复单元浓度为5.0×10-5mol/L,使用甲醇为弱溶剂,三氯甲烷/((R)-(+)-或(S)-(-)-)柠檬烯/甲醇之间的配比为0.3∶1.8∶0.9(V/V/V)时,超支化聚合物圆二色谱光谱强度最强.在三氯甲烷/((R)-(+)-或(S)-(-)-)柠檬烯/甲醇(0.3∶1.8∶0.9(V/V/V))混合溶剂中,聚合物重复单元浓度为5.0×10-5mol/L,超支化聚合物在350～550 nm有较强的紫外吸收,在450～700 nm有较强的荧光发射,组装成的荧光纳米粒子尺寸约为500～2000 nm.     

共轭聚合物荧光纳米粒子研究进展

近年来,共轭聚合物荧光纳米粒子因其优异的光学性能,在化学、医学和环境科学等研究领域显示了极其广阔的应用前景.相比于传统无机半导体荧光纳米材料,共轭聚合物荧光纳米粒子具有结构多样性、功能可设计性、生物相容性好等显著优势.本文从共轭聚合物荧光粒子的制备方法、光学性能、表面功能化修饰出发,重点讨论了近年来共轭聚合物纳米粒子作为荧光探针在细胞成像及生物化学检测方面的研究进展,阐述了当前研究的主要发展方向和仍需解决的问题.     

聚合物纳米粒子用于给药载体

聚合物纳米粒子用于给药载体具有广阔的前景，本文按聚合物纳米粒子的主要制备方法（单体聚合法，聚合物后分散法和两亲性聚合物自组装法等）综述了它近十年来在药物靶向输送上的应用研究进展。     

水滑石型磁性纳米载药粒子的制备及其体外药物释放性能研究

通过调变镁铁尖晶石的含量, 采用一步共沉淀法制备了一系列具有核壳结构的水滑石型磁性纳米载药粒子, 对其微结构、热稳定性、磁性和药物释放性能进行了系统的研究. 结果表明这种磁性纳米载药粒子是一种具有以镁铁尖晶石为核层、双氯酚酸(Diclofenac, DIC)插层水滑石(DIC-LDH)为壳层的复合纳米粒子, 粒径在90～180 nm之间. 其中壳层DIC-LDH的晶粒尺寸D₁₁₀和层板电荷密度随磁核含量的增大而逐渐减小. 磁性纳米载药粒子的载药量随磁核含量的增大而逐渐减小, 而其比饱和磁化强度则随着磁核含量的增大逐渐增大. 体外释放实验表明, 无外加磁场时, 磁核含量增大, 壳层DIC-LDH粒径减小, 磁性纳米载药粒子药物释放速率逐渐增大|外加1500 G磁场时, 磁核含量增大, 磁致团聚程度增大, 其药物释放速率逐渐减小.     

聚磷腈荧光纳米粒子的制备及表征

以六氯环三磷腈(HCCP)和荧光素(FL)为单体、乙腈为溶剂、三乙胺(TEA)为缚酸剂,在室温超声作用下,通过沉淀聚合,成功制备了具有良好荧光性能的聚磷腈纳米粒子(PZF)。通过红外光谱、X射线能谱分析(EDS)、扫描电子显微镜(SEM)和透射电子显微镜(TEM)对PZF的化学结构和组成元素进行了分析。结果表明:制备的PZF是实心结构且粒径均一,具有良好的荧光性能;在365nm紫外光下照射不同时间后PZF的荧光强度几乎没有发生变化,说明制备得到的PZF具有强耐光漂白性。     

金核银壳纳米粒子薄膜的制备及SERS活性研究

采用柠檬酸化学还原法制备金溶胶, 通过自组装技术在石英片表面制备金纳米粒子薄膜, 在银增强剂混合溶液中反应获得金核银壳纳米粒子薄膜. 用紫外-可见吸收光谱仪和原子力显微镜(AFM)研究了不同条件下制备的金核银壳纳米粒子薄膜的光谱特性和表面形貌, 并以结晶紫为探针分子测量了金核银壳纳米粒子薄膜的表面增强拉曼光谱(SERS). 结果表明, 金纳米粒子薄膜的分布、银增强剂反应时间的长短对金核银壳纳米粒子薄膜的形成均有重要影响. 制备过程中, 可以通过控制反应条件获得一定粒径的、具有良好表面增强拉曼散射活性的金核银壳纳米粒子薄膜.     

PLGA-磷酸钙复合载药纳米粒的制备

利用聚氧乙烯硬脂酸酯(Brij78)和帕米膦酸二钠制备新型表面活性剂Pa-Brij78,以此为表面活性剂,聚乳酸-羟基乙酸共聚物(poly(lactic-co-glycolic acid),PLGA)为油相,采用水包油包水的微乳液法制备载卵清蛋白(ovalbumin,OVA)的表面带有磷酸根的PLGA纳米粒,再用共沉淀法在其表面修饰一层磷酸钙,并装载寡核苷酸Cp G,形成一种核-壳结构的复合载药纳米粒Cp G/Ca P/PLGA(OVA).通过动态光散射粒度仪、扫描电子显微镜(SEM)、透射电子显微镜(TEM)、X射线衍射(XRD)对纳米粒进行表征,并测定OVA、Cp G的载药量、包封率.结果表明以Pa-Brij78为表面活性剂制备的PLGA(OVA)纳米粒确实能被磷酸钙修饰,粒径增大40~60 nm,表面变粗糙,XRD测得该磷酸钙层的主要存在形式为Ca3(PO4)2.OVA平均载药量为5%,包封率大于80%;Cp G平均载药量为0.47%,平均包封率为89.9%.     

Fabrication of Novel Reversible Photoswitchable Fluorescent Nanoparticles

Novel photoswitchable fluorescent nanoparticles were fabricated by a facile one-step mini-emulsion polymerization, in which fluorescence resonance energy transfer (FRET) donor, 9,10-diphenylanthracene (DPA), and photoswitchable acceptor, spiropyran derivate, were simultaneously embedded in polymer matrix during the polymerization process. The prepared fluorescent nanoparticles exhibit the typical absorption properties of both DPA dye and spiropyran moiety, indicating that the two chromophores have been incorporated into the polymer nanoparticles. The obtained fluorescent nanoparticles exhibited superior photoswitchable fluorescent performance due to the effective photoinduced interparticle FRET. Moreover, the novel photoswitchable fluorescent nanoparticles also revealed small size (ca. 60 nm), high intensity, relatively fast photoresponsive property and good photoreversibility in aqueous media.     

Synthesis of Folate Conjugated Fluorescent Nanoparticle Probe and Its Application in Cervical Cancer Cell Imaging

Abstract

Cervical cancer is the second most common cancer in women worldwide with 80% of cases arising in the developing world, following cancer of the breast. The mortality associated with cervical cancer can be reduced if this disease is detected in a timely fashion. In this study, a folate conjugated fluorescent nanoparticle (FCFN) probe was used to detect cervical cancer cells. Fluorescent nanoparticles (FNs), with excellent characteristics such as nontoxicity and photostability, were first synthesized with a simple, cost-effective, and environmentally friendly modified St?ber synthesis method and then successfully modified with folate. This kind of fluorescence probe based on FCFNs has been used to detect cervical cancer cells with fluorescence microscopy imaging technology. The experimental results demonstrate that the FCFNs can effectively recognize cervical cancer cells and exhibit good sensitivity and exceptional photostability; they would provide a novel way for the diagnosis and curative effect observation of cervical cancer cells and offer a new method in detecting folate receptors (FR).     

Rubus Capped Zinc Oxide Nanoparticles Induce Apoptosis in MCF-7 Breast Cancer Cells

Rubus fairholmianus (RF) has widely been used to treat various ailments, including pain, diabetes, and cancer. Zinc oxide nanoparticles (ZnO NPs) have drawn attention in modern healthcare applications. Hence, we designed this study to synthesize zinc oxide (ZnO) nanoparticles using R. fairholmianus root extract to investigate its synergistic cytotoxic effect on MCF-7 cells and explore the possible cell death mechanism. ZnO NPs were synthesized via green synthesis using R. fairholmianus root extract, and the effect on MCF-7 cells was determined by looking at cellular morphology, proliferation, cytotoxicity, apoptosis, and reactive oxygen species (ROS). The results showed that cellular proliferation was reduced following treatment with R. fairholmianus capped zinc oxide nanoparticles (RFZnO NPs), while cytotoxicity and ROS were increased. There was also an increase in apoptosis as indicated by the significant increase in cytoplasmic cytochrome c and caspase 3/7 (markers of apoptosis), as well as increased levels of pro-apoptotic proteins (p53, Bax) and decreased levels of anti-apoptotic protein (Bcl-2). In conclusion, these results showed that RFZnO NPs induce apoptosis in breast cancer cells via a mitochondria-mediated caspase-dependent apoptotic pathway and suggest the use of acetone root extract of R. fairholmianus for the treatment of cancer-related ailments.     

绿色荧光蛋白在细胞分析中的应用

本文对绿色荧光蛋白的光谱特性及其在细胞分析中的应用进行了评述。     

Exploring the Interplay between Drug Release and Targeting of Lipid-Like Polymer Nanoparticles Loaded with Doxorubicin

Targeted delivery of doxorubicin still poses a challenge with regards to the quantities reaching the target site as well as the specificity of the uptake. In the present approach, two colloidal nanocarrier systems, NanoCore-6.4 and NanoCore-7.4, loaded with doxorubicin and characterized by different drug release behaviors were evaluated in vitro and in vivo. The nanoparticles utilize a specific surface design to modulate the lipid corona by attracting blood-borne apolipoproteins involved in the endogenous transport of chylomicrons across the blood–brain barrier. When applying this strategy, the fine balance between drug release and carrier accumulation is responsible for targeted delivery. Drug release experiments in an aqueous medium resulted in a difference in drug release of approximately 20%, while a 10% difference was found in human serum. This difference affected the partitioning of doxorubicin in human blood and was reflected by the outcome of the pharmacokinetic study in rats. For the fast-releasing formulation NanoCore-6.4, the AUC_0→1h was significantly lower (2999.1 ng × h/mL) than the one of NanoCore-7.4 (3589.5 ng × h/mL). A compartmental analysis using the physiologically-based nanocarrier biopharmaceutics model indicated a significant difference in the release behavior and targeting capability. A fraction of approximately 7.310–7.615% of NanoCore-7.4 was available for drug targeting, while for NanoCore-6.4 only 5.740–6.057% of the injected doxorubicin was accumulated. Although the targeting capabilities indicate bioequivalent behavior, they provide evidence for the quality-by-design approach followed in formulation development.     

Hybrid Nanoparticles as Drug Carriers for Controlled Chemotherapy of Cancer

Rapid developments in materials science and biological mechanisms have greatly boosted the research discoveries of new drug delivery systems. In the past few decades, hundreds of nanoparticle‐based drug carriers have been reported almost on a daily basis, in which new materials, structures, and mechanisms are proposed and evaluated. Standing out among the drug carriers, the hybrid nanoparticle systems offer a great opportunity for the optimization and improvement of conventional chemotherapy. By combining several features of functional components, these hybrid nanoparticles have shown excellent promises of improved biosafety, biocompatibility, multifunctionality, biodegradability, and so forth. In this Personal Account, we highlight the recent research advances of some representative hybrid nanoparticles as drug delivery systems and discuss their design strategies and responsive mechanisms for controlled drug delivery.     

微型传感器:荧光纳米微球的制备及表征

以丙烯酰胺为基体,N,N-甲叉双丙烯酰胺为交联剂,荧光分子Fura-2作为探针,构造荧光纳米微球。考察了乳化剂用量、引发剂用量、交联剂单体浓度对纳米微球直径和油水比对乳液稳定性的影响。含Fura-2的荧光纳米微球对钙离子非常敏感,可作为钙离子传感器。     

温敏聚合物/纳米CuS复合微球在肿瘤光热化学联合治疗中的应用

利用湿化学法合成了具有光热效应的纳米硫化铜(Cu S)颗粒,采用沉淀聚合法,以N-异丙基丙烯酰胺(NIPAAm)和N-乙烯基吡咯烷酮(NVP)为共聚单体,锂藻土(laponite)作为交联剂,吸附纳米硫化铜,制备出兼具光热效应和温敏响应性的复合微凝胶[P(NIPAAm-co-NVP)/Cu S](NNC/Cu S),并测试其载药和药物缓释性能.实验结果表明,制备的纳米Cu S和NNC/Cu S复合微凝胶均在近红外区有很宽的光谱吸收带,在980 nm(0.51 W/cm2)激光的辐照条件下,NNC/Cu S复合微凝胶具有良好的光热效应,温度在8 min内可以升至51.9℃,对于Hela细胞杀伤效果明显,并随着激光照射时间的延长效果越好.复合微凝胶的载药量为0.15mg/mg,在p H=5.5的PBS缓冲液中累积药物释放为75%,高于p H=7.4的63%.同时光热效应对于温敏性载药微球的药物释放具有有效地调控作用,在药物释放阶段,激光照射段药物释放率明显高于未加激光照射段.另外聚合物与纳米Cu S的复合改善了纳米Cu S对于细胞的毒性,NNC/Cu S复合微凝胶细胞存活率为90.9%高于纳米Cu S的63%.